This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2004.
Company Filing History:
2 out of 834,411 Years Active: 2004
Title: James C Engert: Innovator in Genetic Research
Introduction
James C Engert is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of genetic research, particularly in the study of lipoprotein receptors and neurodegenerative diseases. With a total of 2 patents, Engert's work has implications for both diagnosis and treatment in medical science.
Latest Patents
Engert's latest patents include "Very low density lipoprotein receptor polymorphisms and uses therefor." This patent describes polymorphic nucleic acid molecules that encode the very low density lipoprotein receptor, along with allele-specific primers and probes for diagnostic use. Another significant patent is "Identification of arsacs mutations and methods of use therefor," which discloses isolated spastin genes and proteins, as well as methods for diagnosing and treating neurodegenerative diseases.
Career Highlights
Throughout his career, Engert has focused on advancing our understanding of genetic factors that contribute to various health conditions. His innovative approaches have led to breakthroughs that enhance the potential for targeted therapies.
Collaborations
Engert has collaborated with esteemed colleagues such as Thomas J Hudson and Marie-Claude Vohl, further enriching his research endeavors and expanding the impact of his work.
Conclusion
James C Engert stands out as a prominent figure in genetic research, with patents that pave the way for advancements in medical diagnostics and treatments. His contributions continue to influence the field and inspire future innovations.